In our study, serum nesfatin-1 levels in T2DM were obviously reduced compared to that in prediabetes or healthy subjects, which was supported by other evidences (40, 41), and this reduction still presented when comparing prediabetes to the control, which has not been reported so far. This evidence concerns the gene NUCB2 and type 2 diabetes mellitus.